- Gavi, the Vaccine Alliance, secures $9 billion funding from global donors
- Forty-three Sub-Saharan African nations on a climate ‘red zone’ list
- Last year 20 people died daily due to opioid overdose in Canada: Govt. data
- Gilead, Kymera Therapeutics in $750m pact to make new cancer drug
- Large language models reduce brain activity, produce ‘soulless’ essays: MIT
- Illumina to acquire proteomics company SomaLogic in $425 million all cash deal
- Novo terminates agreement with Hims & Hers to sell weight-loss drug
- Axolotls may hold the key to human organ regeneration: US researchers
- ‘Menstrual tracking data being used to control people’s reproductive lives’
- Novo Nordisk’s obesity drug CagriSema cuts weight by 23%
- Madrigal’s therapy to treat MASH in adults gets EU’s initial nod
- Supernus Pharma to acquire Sage Therapeutics for $795 million all cash
- Novo Nordisk’s amycretin drug helps obese adults lose 24% weight
- Wegovy’s weight-loss efficacy improves with higher dosage
- UK health agency, Met Office, issues an amber alert as temperatures rise
Opinion
